Index
1 Market Overview
1.1 Product Overview and Scope of Non-Benzodiazepines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-Benzodiazepines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Dexmedetomidine
1.3.3 Zolpidem
1.3.4 Eszopiclone
1.3.5 Zopiclone
1.3.6 other
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-Benzodiazepines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-Benzodiazepines Market Size & Forecast
1.5.1 Global Non-Benzodiazepines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-Benzodiazepines Sales Quantity (2018-2029)
1.5.3 Global Non-Benzodiazepines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Non-Benzodiazepines Product and Services
2.1.4 Pfizer Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Non-Benzodiazepines Product and Services
2.2.4 Teva Pharmaceuticals Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Pharmaceuticals Recent Developments/Updates
2.3 Torrent Pharma
2.3.1 Torrent Pharma Details
2.3.2 Torrent Pharma Major Business
2.3.3 Torrent Pharma Non-Benzodiazepines Product and Services
2.3.4 Torrent Pharma Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Torrent Pharma Recent Developments/Updates
2.4 Accord Healthcare
2.4.1 Accord Healthcare Details
2.4.2 Accord Healthcare Major Business
2.4.3 Accord Healthcare Non-Benzodiazepines Product and Services
2.4.4 Accord Healthcare Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Accord Healthcare Recent Developments/Updates
2.5 Akorn
2.5.1 Akorn Details
2.5.2 Akorn Major Business
2.5.3 Akorn Non-Benzodiazepines Product and Services
2.5.4 Akorn Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Akorn Recent Developments/Updates
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Non-Benzodiazepines Product and Services
2.6.4 Apotex Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Apotex Recent Developments/Updates
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Non-Benzodiazepines Product and Services
2.7.4 Fresenius Kabi Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fresenius Kabi Recent Developments/Updates
2.8 Hikma
2.8.1 Hikma Details
2.8.2 Hikma Major Business
2.8.3 Hikma Non-Benzodiazepines Product and Services
2.8.4 Hikma Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hikma Recent Developments/Updates
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Non-Benzodiazepines Product and Services
2.9.4 Mylan Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments/Updates
2.10 Par Pharmaceuticals
2.10.1 Par Pharmaceuticals Details
2.10.2 Par Pharmaceuticals Major Business
2.10.3 Par Pharmaceuticals Non-Benzodiazepines Product and Services
2.10.4 Par Pharmaceuticals Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Par Pharmaceuticals Recent Developments/Updates
2.11 Sandoz
2.11.1 Sandoz Details
2.11.2 Sandoz Major Business
2.11.3 Sandoz Non-Benzodiazepines Product and Services
2.11.4 Sandoz Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sandoz Recent Developments/Updates
2.12 Sun Pharma
2.12.1 Sun Pharma Details
2.12.2 Sun Pharma Major Business
2.12.3 Sun Pharma Non-Benzodiazepines Product and Services
2.12.4 Sun Pharma Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sun Pharma Recent Developments/Updates
2.13 WG Critical Care
2.13.1 WG Critical Care Details
2.13.2 WG Critical Care Major Business
2.13.3 WG Critical Care Non-Benzodiazepines Product and Services
2.13.4 WG Critical Care Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 WG Critical Care Recent Developments/Updates
2.14 Athenex
2.14.1 Athenex Details
2.14.2 Athenex Major Business
2.14.3 Athenex Non-Benzodiazepines Product and Services
2.14.4 Athenex Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Athenex Recent Developments/Updates
2.15 Chenxin Pharmaceutical
2.15.1 Chenxin Pharmaceutical Details
2.15.2 Chenxin Pharmaceutical Major Business
2.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Product and Services
2.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Chenxin Pharmaceutical Recent Developments/Updates
2.16 Huatai Chenguang Pharmaceutical
2.16.1 Huatai Chenguang Pharmaceutical Details
2.16.2 Huatai Chenguang Pharmaceutical Major Business
2.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product and Services
2.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Huatai Chenguang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Non-Benzodiazepines by Manufacturer
3.1 Global Non-Benzodiazepines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-Benzodiazepines Revenue by Manufacturer (2018-2023)
3.3 Global Non-Benzodiazepines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-Benzodiazepines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-Benzodiazepines Manufacturer Market Share in 2022
3.4.2 Top 6 Non-Benzodiazepines Manufacturer Market Share in 2022
3.5 Non-Benzodiazepines Market: Overall Company Footprint Analysis
3.5.1 Non-Benzodiazepines Market: Region Footprint
3.5.2 Non-Benzodiazepines Market: Company Product Type Footprint
3.5.3 Non-Benzodiazepines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-Benzodiazepines Market Size by Region
4.1.1 Global Non-Benzodiazepines Sales Quantity by Region (2018-2029)
4.1.2 Global Non-Benzodiazepines Consumption Value by Region (2018-2029)
4.1.3 Global Non-Benzodiazepines Average Price by Region (2018-2029)
4.2 North America Non-Benzodiazepines Consumption Value (2018-2029)
4.3 Europe Non-Benzodiazepines Consumption Value (2018-2029)
4.4 Asia-Pacific Non-Benzodiazepines Consumption Value (2018-2029)
4.5 South America Non-Benzodiazepines Consumption Value (2018-2029)
4.6 Middle East and Africa Non-Benzodiazepines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-Benzodiazepines Sales Quantity by Type (2018-2029)
5.2 Global Non-Benzodiazepines Consumption Value by Type (2018-2029)
5.3 Global Non-Benzodiazepines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-Benzodiazepines Sales Quantity by Application (2018-2029)
6.2 Global Non-Benzodiazepines Consumption Value by Application (2018-2029)
6.3 Global Non-Benzodiazepines Average Price by Application (2018-2029)
7 North America
7.1 North America Non-Benzodiazepines Sales Quantity by Type (2018-2029)
7.2 North America Non-Benzodiazepines Sales Quantity by Application (2018-2029)
7.3 North America Non-Benzodiazepines Market Size by Country
7.3.1 North America Non-Benzodiazepines Sales Quantity by Country (2018-2029)
7.3.2 North America Non-Benzodiazepines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-Benzodiazepines Sales Quantity by Type (2018-2029)
8.2 Europe Non-Benzodiazepines Sales Quantity by Application (2018-2029)
8.3 Europe Non-Benzodiazepines Market Size by Country
8.3.1 Europe Non-Benzodiazepines Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-Benzodiazepines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-Benzodiazepines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-Benzodiazepines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-Benzodiazepines Market Size by Region
9.3.1 Asia-Pacific Non-Benzodiazepines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-Benzodiazepines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-Benzodiazepines Sales Quantity by Type (2018-2029)
10.2 South America Non-Benzodiazepines Sales Quantity by Application (2018-2029)
10.3 South America Non-Benzodiazepines Market Size by Country
10.3.1 South America Non-Benzodiazepines Sales Quantity by Country (2018-2029)
10.3.2 South America Non-Benzodiazepines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-Benzodiazepines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-Benzodiazepines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-Benzodiazepines Market Size by Country
11.3.1 Middle East & Africa Non-Benzodiazepines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-Benzodiazepines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-Benzodiazepines Market Drivers
12.2 Non-Benzodiazepines Market Restraints
12.3 Non-Benzodiazepines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-Benzodiazepines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-Benzodiazepines
13.3 Non-Benzodiazepines Production Process
13.4 Non-Benzodiazepines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-Benzodiazepines Typical Distributors
14.3 Non-Benzodiazepines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer